发明名称 |
Antisense-induced exon2 inclusion in acid alpha-glucosidase |
摘要 |
The present disclosure relates to antisense oligomers and related compositions and methods for inducing exon inclusion as a treatment for glycogen storage disease type II (GSD-II) (also known as Pompe disease, glycogenosis II, acid maltase deficiency (AMD), acid alpha-glucosidase deficiency, and lysosomal alpha-glucosidase deficiency), and more specifically relates to inducing inclusion of exon 2 and thereby restoring levels of enzymatically active acid alpha-glucosidase (GAA) protein encoded by the |
申请公布号 |
AU2014317961(A1) |
申请公布日期 |
2016.03.17 |
申请号 |
AU20140317961 |
申请日期 |
2014.09.05 |
申请人 |
MURDOCH UNIVERSITY;SAREPTA THERAPEUTICS, INC. |
发明人 |
WILTON, STEPHEN DONALD;FLETCHER, SUE;HANSON, GUNNAR JAMES;BESTWICK, RICHARD KEITH |
分类号 |
C12N15/113;A61K31/712;A61K31/7125;C07H21/00 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|